Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-04-01
2000-12-19
Seaman, D. Margaret
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546146, C07D21706, A61K 3147
Patent
active
061628123
ABSTRACT:
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain these compounds and optically other anti-viral agents as active ingredients, are suitable for treating patients or hosts infected with the HIV virus, which is known to cause AIDS.
REFERENCES:
patent: 5063208 (1991-11-01), Rosenberg et al.
patent: 5142056 (1992-08-01), Kempe et al.
patent: 5157041 (1992-10-01), Handa et al.
patent: 5196438 (1993-03-01), Martin et la.
patent: 5204471 (1993-04-01), Negele et al.
patent: 5235039 (1993-08-01), Heath, Jr. et al.
patent: 5434265 (1995-07-01), Fritz et al.
patent: 5475136 (1995-12-01), Fritz et al.
patent: 5484926 (1996-01-01), Dressman et al.
patent: 5491166 (1996-02-01), Kaldor et al.
patent: 5508407 (1996-04-01), Kaldor et al.
patent: 5527829 (1996-06-01), Kalish et al.
patent: 5554653 (1996-09-01), Hui et al
patent: 5733906 (1998-03-01), Jungheim et al.
patent: 5824688 (1998-10-01), Kalish et al.
patent: 5827858 (1998-10-01), Kalish et al.
patent: 5827859 (1998-10-01), Kalish et al.
patent: 5827891 (1998-10-01), Dressman et al.
patent: 5834467 (1998-11-01), Kalish et al.
patent: 5837710 (1998-11-01), Hornback et al.
patent: 5846993 (1998-12-01), Dressman et al.
patent: 5852043 (1998-12-01), Kalish et al.
patent: 5859002 (1999-01-01), Kalish et al.
Tam et al., J. Med. Chem., 35(7):1318-1320 (1992).
Huff, J. Med. Chem., 34(8):2305-2314 (1991).
Ghosh et al., J. Med. Chem., 36(2):292-294 (1993).
Ghosh et al., J. Med. Chem., 36(16):2300-2310 (1993).
Thompson et al., J. Am. Chem. Soc., 115(2):801-802 (1993).
Rich et al., J. Med. Chem., 34(3):1222-1225 (1991).
Thaisvivongs et al., J. Med. Chem., 34:2344-2356 (1991).
Ghosh et al., J. Med. Chem., 36:924-927 (1993).
Chong et al., J. Med. Chem., 36:2575-2577 (1993).
Vava Pradad et al., Peptides, Chemistry and Biology, Proceedings of the Twelfth American Peptide Symposium, Jun. 16-21, 1991, pp. 721-722.
Rich et al., Chem. Abstracts, 114(15) Abstract No. 143398g (1991).
Houpis et al., Tetrahedron Letters, 34(16):2593-2596 (1993).
Roberts, N.A. et al., Science, 248:358-361 (1990).
Gilbert et al., J. Chem. Soc. Perkin Trans., 2:475-479 (1993).
Young et al., J. Med. Chem., 35:1702-1709 (1992).
Lyle et al., J. Med. Chem., 34:1228-1230 (1991).
Kaldor et al., "VIRACEPT.RTM. Nelfinavir," Protease Inhibitors Discovers Award, pp. 21-23 (1993).
Dressman Bruce A.
Fritz James E.
Hammond Marlys
Hornback William J.
Kaldor Stephen W.
Agouron Pharmaceuticals , Inc.
Seaman D. Margaret
LandOfFree
Pharmaceutical compositions containing HIV protease inhibitors a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions containing HIV protease inhibitors a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing HIV protease inhibitors a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-271571